Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Raymond T. Keane currently holds 24,124 shares of ARIAD PHARMACEUTICALS INC (ARIA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Raymond T. Keane has been a net seller of ARIA stock. They have purchased $0 and sold $2.0M worth of shares.
Raymond T. Keane's most recent insider trade was on Feb 11, 2022, when they sold 22,500 shares at $0.00 per share.
Raymond T. Keane serves as Executive at ARIAD PHARMACEUTICALS INC (ARIA). They have executed 30 insider transactions totaling $2.0M over their tenure at the company.
Raymond T. Keane holds the position of Executive at ARIAD PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Raymond T. Keane has shown a selling trading pattern, with $0 in total purchases and $2.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Raymond T. Keane was on Mar 25, 2013, when they sold $248.5K worth of ARIA shares. This transaction involved 13,167 shares at $18.87 per share.
Raymond T. Keane currently owns 24,124 shares of ARIAD PHARMACEUTICALS INC (ARIA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Raymond T. Keane's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Raymond T. Keane has 30 Form 4 filings on record as an insider at ARIAD PHARMACEUTICALS INC.
Set alerts for Raymond T. Keane and 40,000+ other insiders.